CPHPC(Miridesap)
产品编号: DC10506
Featured
我们的合作伙伴:
中国地区超过5000个高品质化合物库存
应用领域
Miridesap 是血清淀粉样蛋白 P 组分 (SAP) 的配体,能抑制和解离 SAP 与淀粉状蛋白原纤维的结合。
Cas No.: |
224624-80-0 |
名称: |
|
别名: |
Miridesap; Ro-638695; Ro 638695; Ro638695;CPHPC;CPOHPC (acid form; CPOHPC acid |
SMILES: |
O=C(N1[C@H](CCC1)C(O)=O)CCCCC(N2[C@H](CCC2)C(O)=O)=O |
分子式: |
C16H24N2O6 |
分子量: |
340.4 |
纯度: |
|
保存条件: |
2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: |
|
In Vivo: |
|
In Vitro: |
|
References: |
Miridesap (also known as Ro-638695, GSK-2315698, and CPHPC) is an antineoplastic which depletes circulating serum amyloid P component (SAP) almost completely but leaves some SAP in amyloid deposits for specific recognition by subsequently administered therapeutic anti-SAP antibodies. Since Miridesap removes SAP from the blood, it also removes SAP from the cerebrospinal fluid (CSF). |
Kinase Assay: |
|
Cell Assay: |
|
Animal Administration: |
|
References: |
|
MSDS
TITLE |
DOWNLOAD |
MSDS_275_DC10506_224624-80-0 |
|
COA
LOT NO. |
DOWNLOAD |
|
|
询盘